DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Catapres-TTS (Clonidine Hydrochloride Transdermal) - Published Studies


Catapres-TTS Related Published Studies

Well-designed clinical trials related to Catapres-TTS (Clonidine Transdermal)

A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study. [2014]

[Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children] [2009.07]

Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. [2008.09]

Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. [2006.03]

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. [2003.04.01]

Transdermal clonidine: does it affect pain after abdominal hysterectomy? [2003]

Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure. [2001.08]

Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. [1998.08]

Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus. [1998.02]

Sympathetic inhibition with clonidine improves autonomic balance in congestive heart failure. [1997.04.18]

Postoperative analgesia using a low-dose, oral-transdermal clonidine combination: lack of clinical efficacy. [1997.02]

Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies. [1997.01]

Clonidine in the management of asymmetrical gustatory facial sweating: an N-of-1 trial. [1996.09]

Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients. [1996.02.22]

Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. [1995.03]

Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. [1994.12]

Transdermal clonidine for ameliorating post-orchiectomy hot flashes. [1994.03]

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. [1994.01]

Epidural clonidine treatment for refractory reflex sympathetic dystrophy. [1993.12]

Randomized, controlled trial of transdermal clonidine for smoking cessation. [1993.09]

Perioperative platelet reactivity and the effects of clonidine. [1993.08]

Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation. [1992.10]

Transdermal clonidine versus placebo in painful diabetic neuropathy. [1992.03]

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. [1992.03]

Transdermal delivery of the alpha 2-agonist clonidine does not alter airways responses to inhaled histamine or methacholine. [1991.10]

Transdermal and oral clonidine. [1991.08]

Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. [1991.07.18]

Skin pretreatment and the use of transdermal clonidine. [1991.07.18]

Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. [1991.03]

Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period. [1991.02]

A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension. [1990.03]

Efficacy of transdermal clonidine for headache prophylaxis and reduction of narcotic use in migraine patients. A randomized crossover trial. [1989.08]

Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. [1989.07]

Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial. [1988.09]

Randomized, double-blind comparison of transdermal clonidine with oral propranolol. [1987]

Well-designed clinical trials possibly related to Catapres-TTS (Clonidine Transdermal)

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. [2005.10]

Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. [1999.02]

Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women. [1997.12.15]

The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women. [1991]

Antismoking products. [1990.12.03]

Other research related to Catapres-TTS (Clonidine Transdermal)

The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence. [2010.09]

Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release. [2007.06]

Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study. [2006.11]

A new copolymer membrane controlling clonidine linear release in a transdermal drug delivery system. [2006.09.28]

Transdermal estradiol priming during clonidine stimulation test in non-growth hormone deficient children with short stature: a pilot study. [2006.03]

Sympathetic overactivity in active ulcerative colitis: effects of clonidine. [2006.01]

Transdermal clonidine: therapeutic considerations. [2005.09]

In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. [2005.02]

[Determination of clonidine in rabbit plasma by HPLC-MS] [2004.05]

Carrier-mediated transport of clonidine in human keratinocytes. [2004.02]

Clonidine for smoking cessation. [2004]

Intentional clonidine patch ingestion by 3 adults in a detoxification unit. [2003.02.10]

Clonidine-induced hypertension in a patient with a spinal lesion. [2002.09]

[A case of effective treatment with clonidine ointment for herpetic neuralgia after bone marrow transplantation in a child] [2002.07]

Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm. [2002.07]

Transdermal clonidine skin reactions. [2002.03]

[Preliminary report: the efficacy of clonidine hydrochloride ointment for postherpetic neuralgia] [2001.02]

Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. [2001.01]

Clonidine for smoking cessation. [2000]

Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides. [1999.03]

Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics. [1999.01]

Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients. [1999.01]

Usefulness of transdermal clonidine in hypertensive patients undergoing minor surgical operations. [1998.12]

Effect of clonidine on heart rate variability in congestive heart failure. [1998.08.01]

Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats. [1998.08]

Transdermal clonidine in the prophylaxis of episodic cluster headache: an open study. [1997.10]

"Cloniderm" toxicity: another manifestation of clonidine overdose. [1997.10]

Effects of clonidine on prolonged postoperative sympathetic response. [1997.07]

Transdermal clonidine therapy and blood pressure nocturnal fall in mild hypertensive male subjects. [1997.04]

Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. [1996.11]

Clonidine: a practical guide for usage in children. [1996.07]

Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. [1996.03]

Effects of a newly developed transdermal clonidine delivery system (M-5041T) on EEG sleep-wake cycle in relation to plasma concentration in rabbits. [1996.01]

Preclinical assessment of a new transdermal delivery system for clonidine (M-5041T). [1996]

Hypotensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously and renal hypertensive rats. [1995.12]

Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study. [1995.10]

Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports. [1995.08]

Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats. [1994.05]

Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects. [1994.03]

Determination of clonidine in human plasma by gas chromatography-electron-impact mass spectrometry. [1994.02.18]

The USA experience with the clonidine transdermal therapeutic system. [1993.12]

Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. [1993.12]

Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension. [1993.12]

Dose linearity of clonidine after transdermal application. [1993.12]

Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects. [1993.12]

Influence of application site of a new transdermal clonidine, M-5041T, on its pharmacokinetics and pharmacodynamics in healthy subjects. [1993.12]

Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. [1993.11]

Transdermal clonidine as an adjunct to nifedipine-GITS therapy in patients with mild-to-moderate hypertension. [1993.10]

Effect of transdermal clonidine on spinal spasticity. A case series. [1993.06]

Clonidine patch ingestion in an adult. [1993.06]

Use of clonidine to treat hot flashes secondary to leuprolide or goserelin. [1993.02]

The use of transdermal clonidine in the hypertensive patient with chronic renal failure. [1993.01]

Use of transdermal clonidine in chronic hemodialysis patients. [1993.01]

[Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation] [1992.09]

Clonidine transdermal system for treatment of spasticity in spinal cord injury. [1992.09]

Transdermal clonidine as an adjunct to enalapril: an evaluation of efficacy and patient compliance. [1992.05]

Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. [1991.12]

Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension. [1991.07]

Clonidine patch toxicity. [1990.12]

Self-injurious behavior associated with clonidine withdrawal in a child with Tourette's disorder. [1990.10]

Low allergenicity of clonidine impedes studies of sensitization mechanisms in guinea pig models. [1990.08]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017